Table 3.
Comparing clinical findings between Marsh I-II and Marsh IIIa-c in 111 patients with malabsorption syndrome and abnormal histology
Variable | Marsh 0 | Marsh I | Marsh II | Marsh IIIa-c | p-value |
---|---|---|---|---|---|
N = 13/111 | N = 11/111 | N = 27/111 | N = 60/111 | ||
chronic diarrhea | 3 (23%) | 9(82%) | 18(66.6%) | 43 (71.7%) | 0.005 |
Failure to thrive | 7(53.8%) | 9(81.8%) | 20(74%) | 44(73.3%) | 0.43 |
Short stature | 7(53.8%) | 7(63.6%) | 15 (70.3%) | 33(55%) | 0.96 |
Abdominal pain | 5(38.5%) | 4(36.4%) | 17(63%) | 36(60%) | 0.24 |
Abdominal distension | 4(30.8%) | 5(45.5%) | 15(55.5%) | 30(50%) | 0.52 |
Fatty stool | 1(7.7%) | 4(36.4%) | 10(37%) | 39(65%) | 0.001 |
Decreased appetite | 4(30.8%) | 4(36.4%) | 10(37%) | 30(50%) | 0.56 |
constipation | 3(23%) | 4(36.4%) | 6(22.2%) | 3 (5%) | 0.01 |
vomiting | 2(15.4%) | 4(36.4%) | 5(22.7%) | 21(35%) | 0.27 |
rickets | 0 | 0 | 3(11.1%) | 11(18.3%) | 0.16 |
Tibial edema | 0 | 0 | 1(3.7%) | 6(10%) | 0.54 |
Anemia | 3(23%) | 4(36.4%) | 13(48.1%) | 46(76.7%) | 0.001 |
EMA | 10(79.9%) | 2(18.2%) | 12(44.4%) | 52(86.7%) | 0.001 |